Their initial study in vitro showed that the ratio of phospho-ERK to Spry2 in the HCC cell lines MHCC97L, HCCLM3, and HCCLM6 displayed an elevation concordant with their stepwise metastatic potential. The gene discussed is SPRY2; the disease is hepatocellular carcinoma.